The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast | A 70-year-old man with CKD G4, osteoporosis and low bone turnover

A 70-year-old man with CKD G4, osteoporosis and low bone turnover